Intervention Review

Interventions for treating depression after stroke

  1. Maree L Hackett1,*,
  2. Craig S Anderson1,
  3. Allan House2,
  4. Jun Xia3

Editorial Group: Cochrane Stroke Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 25 MAY 2008

DOI: 10.1002/14651858.CD003437.pub3

How to Cite

Hackett ML, Anderson CS, House A, Xia J. Interventions for treating depression after stroke. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD003437. DOI: 10.1002/14651858.CD003437.pub3.

Author Information

  1. 1

    The George Institute for International Health, Department of Neurological and Mental Health, Sydney, NSW, Australia

  2. 2

    University of Leeds, Leeds Institute of Health Sciences, Leeds, UK

  3. 3

    Bridge House, Cochrane Schizophrenia Group, Leeds, UK

*Maree L Hackett, Department of Neurological and Mental Health, The George Institute for International Health, PO Box M201, Missenden Road, Sydney, NSW, 2050, Australia.

Publication History

  1. Publication Status: New search for studies and content updated (conclusions changed)
  2. Published Online: 8 OCT 2008




  1. Top of page
  2. Abstract
  3. Plain language summary
  4. アブストラクト
  5. 摘要


Depression is an important consequence of stroke that impacts on recovery yet is often not detected or inadequately treated. This is an update of a Cochrane review first published in 2004.


To determine whether pharmaceutical, psychological, or electroconvulsive treatment (ECT) of depression in patients with stroke can improve outcome.

Search methods

We searched the trials registers of the Cochrane Stroke Group (last searched October 2007) and the Cochrane Depression Anxiety and Neurosis Group (last searched February 2008). In addition, we searched the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 1, 2008), MEDLINE (1966 to May 2006), EMBASE (1980 to May 2006), CINAHL (1982 to May 2006), PsycINFO (1967 to May 2006) and other databases. We also searched reference lists, clinical trials registers, conference proceedings and dissertation abstracts, and contacted authors, researchers and pharmaceutical companies.

Selection criteria

Randomised controlled trials comparing pharmaceutical agents with placebo, or various forms of psychotherapy or ECT with standard care (or attention control), in patients with stroke, with the intention of treating depression.

Data collection and analysis

Two review authors selected trials for inclusion and assessed methodological quality; three review authors extracted, cross-checked and entered data. Primary analyses were the prevalence of diagnosable depressive disorder at the end of treatment. Secondary outcomes included depression scores on standard scales, physical function, death, recurrent stroke and adverse effects.

Main results

Sixteen trials (17 interventions), with 1655 participants, were included in the review. Data were available for 13 pharmaceutical agents, and four trials of psychotherapy. There were no trials of ECT. The analyses were complicated by the lack of standardised diagnostic and outcome criteria, and differing analytic methods. There was some evidence of benefit of pharmacotherapy in terms of a complete remission of depression and a reduction (improvement) in scores on depression rating scales, but there was also evidence of an associated increase in adverse events. There was no evidence of benefit of psychotherapy.

Authors' conclusions

A small but significant effect of pharmacotherapy (not psychotherapy) on treating depression and reducing depressive symptoms was found, as was a significant increase in adverse events. More research is required before recommendations can be made about the routine use of such treatments.


Plain language summary

  1. Top of page
  2. Abstract
  3. Plain language summary
  4. アブストラクト
  5. 摘要

Interventions for treating depression after stroke

Antidepressant drugs may be useful in treating depression after stroke, but also cause side effects. Depression is common after stroke and may be treated with antidepressant medication or psychological therapy. This review of 16 trials, including 1655 participants, found that antidepressant drugs may produce recovery or improve depression symptoms. However they also increase side effects. These drugs should be used with caution in people with persistent depressive symptoms after stroke, as little is known about the risks, especially of seizures, falls, and delirium. We found no evidence for the benefit of psychotherapy. Future research should include a broader group of stroke patients.



  1. Top of page
  2. Abstract
  3. Plain language summary
  4. アブストラクト
  5. 摘要







Trials registers of Cochrane Stroke Group(2007年10月まで検索)およびCochrane Depression Anxiety and Neurosis Group(2008年2月まで検索)を検索した。また、Cochrane Central Register of Controlled Trials(コクラン・ライブラリ2008年第1号)、MEDLINE(1996年~2006年5月)、EMBASE(1980年~2006年5月)、CINAHL(1982年~2006年5月)、PsycINFO(1966年~2006年5月)、その他のデータベースも検索した。さらに、参考文献リスト、臨床試験登録、カンファレンス予稿集および学位論文抄録を検索し、著者、研究者および製薬会社に問い合わせた。










監  訳: 大神 英一,2009.2.20

実施組織: 厚生労働省委託事業によりMindsが実施した。

ご注意 : この日本語訳は、臨床医、疫学研究者などによる翻訳のチェックを受けて公開していますが、訳語の間違いなどお気づきの点がございましたら、Minds事務局までご連絡ください。Mindsでは最新版の日本語訳を掲載するよう努めておりますが、編集作業に伴うタイム・ラグが生じている場合もあります。ご利用に際しては、最新版(英語版)の内容をご確認ください。



  1. Top of page
  2. Abstract
  3. Plain language summary
  4. アブストラクト
  5. 摘要







我們搜查了the trials registers of the Cochrane Stroke Group (搜尋至2007年10月)以及 the Cochrane Depression Anxiety and Neurosis Group (搜尋至2008年2月)。此外,我們搜尋了Cochrane Central Register of Controlled Trials (The Cochrane Library,2008年第1期)、 MEDLINE (1966年至2006年5月)、EMBASE (1980年至2006年5月)CINAHL (1982年至2006年5月)、PsycINFO (1967年至2006年5月)以及其他資料庫。我們還搜尋參考文獻、臨床試驗資料庫、研討會摘要手冊及論文摘要,並聯絡作者、研究者與藥廠。


比較不同種類的藥劑與安慰劑,或各種心理治療或ETC加上標準照護(或注意力控制)的隨機對照試驗(randomised controlled trials)於中風病人且具有明確治療憂鬱症的意向者。









此翻譯計畫由臺灣國家衛生研究院(National Health Research Institutes, Taiwan)統籌。